TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26963599

Group type: EXPERIMENTAL
Intervention: Bikram Yoga practice
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 52
Study: 24463131

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60
Study: 22582690

Group type: EXPERIMENTAL
Intervention: Magnetic fields (30 min exposure)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 37
Study: 20926506

Group type: EXPERIMENTAL
Intervention: Palovarotene©, an orally active, gamma selective retinoid agonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18273733

Group type: EXPERIMENTAL
Intervention: Insulin glargine (Lantus) daily from start of surgery
Number of subjects: 43

Group type: COMPARATOR
Intervention: Regular insulin (Actrapid) when needed (sliding scale)
Number of subjects: 43
Study: 16086938

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 14703

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Both (valsartan and captopril)
Number of subjects: 14703
Study: 12170023

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of methylprednisolone (10 mg/kg body weight) 30 minutes before surgery (MP group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo infusion (control group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of methylprednisolone (MP group)
Number of subjects: 66
Study: 10093840

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty (PTA) alone
Number of subjects: 62

Group type: COMPARATOR
Intervention: Balloon angioplasty followed by implantation of Palmaz stents
Number of subjects: 62
Study: 8643415

Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes mellitus (IDDM) patients
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy age-matched subjects (control group)
Number of subjects: 58
Study: 1976147

Group type: EXPERIMENTAL
Intervention: Oxygen-enriched (33% oxygen)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Carbon-dioxide-enriched (3% carbon dioxide)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal compressed air
Number of subjects: 20
Study: 7222702

Group type: EXPERIMENTAL
Intervention: L-dopa
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: prodipine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: amantadine
Number of subjects: 43
Study: 30498987

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dialectical-behavior therapy (DBT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT) or Dialectical-behavior therapy (DBT)
Number of subjects: 50
Study: 30878190

Group type: EXPERIMENTAL
Intervention: Working Memory Training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Active Control Group
Number of subjects: 32
Study: 28510730

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 252

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 252
Study: 25377933

Group type: EXPERIMENTAL
Intervention: MK-3207 (20 mg dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MK-3207 (40-100 mg dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CGRP receptor antagonists
Number of subjects: 0
Study: 23728118

Group type: EXPERIMENTAL
Intervention: Prescription chart design from NHS Highland
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Prescription chart design from NHS Grampian
Number of subjects: 72

Group type: COMPARATOR
Intervention: Other three prescription chart designs
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Time taken to complete prescriptions
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Familiarity with a chart
Number of subjects: 72
Study: 21345844

Group type: EXPERIMENTAL
Intervention: GDF‐15 concentrations above the median on admission
Number of subjects: 238

Group type: COMPARATOR
Intervention: Myocardial salvage
Number of subjects: 238
Study: 19268392

Group type: EXPERIMENTAL
Intervention: Experimental anxiety induction
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study: 16171630

Group type: EXPERIMENTAL
Intervention: IA tramadol 50 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: IA morphine 5 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: IA normal saline (control group)
Number of subjects: 75
Study: 11911025

Group type: EXPERIMENTAL
Intervention: Trained nurse case managers
Number of subjects: 101

Group type: COMPARATOR
Intervention: Untrained nurse case managers
Number of subjects: 101
Study: 10421669

Group type: EXPERIMENTAL
Intervention: Consensus interferon (CIFN) 15 mcg for 12 months
Number of subjects: 467

Group type: COMPARATOR
Intervention: Initial interferon treatment (either 9 mcg CIFN or 3 MU IFN-alpha2b 3 times per week)
Number of subjects: 467
Study: 7671894

Group type: EXPERIMENTAL
Intervention: Physical training (3 months, exercising on a bicycle ergometer for 30 min three times a week at 50-60% of peak oxygen consumption)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 2210807

Group type: EXPERIMENTAL
Intervention: Low alcohol beer (reduced from 537 to 57 ml/week)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Normal alcohol intake (543 to 557 ml/week)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low sodium diet with placebo sodium chloride tablets
Number of subjects: 63

Group type: COMPARATOR
Intervention: Normal sodium intake with 100 mmol/day sodium chloride tablets
Number of subjects: 63
Study: 6252180

Group type: EXPERIMENTAL
Intervention: Cefotaxime 1.0 to 1.5 mg/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Amikacin 0.75 mg/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cefotaxime 1.0 to 1.5 mg/kg + Amikacin 0.75 mg/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cefotaxime 15 mg/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Amikacin 15 mg/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cefotaxime 15 mg/kg + Amikacin 15 mg/kg
Number of subjects: 26
Study: 31828841

Group type: EXPERIMENTAL
Intervention: Rapid rehydration (intravenous fluid over six hours)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Slow rehydration (intravenous fluid over 12 hours)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Rapid rehydration
Number of subjects: 208

Group type: COMPARATOR
Intervention: Slow rehydration
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 208
Study: 30678465

Group type: EXPERIMENTAL
Intervention: n3PUFA (4 g/d)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Soy oil control
Number of subjects: 98
Study: 28520849

Group type: EXPERIMENTAL
Intervention: Beta blockers (BB)
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: Beta blockers (BB) after enrolment
Number of subjects: 1144

Group type: EXPERIMENTAL
Intervention: Beta blockers (BB) in TNBC subset
Number of subjects: 1144
Study: 25872612

Group type: EXPERIMENTAL
Intervention: Dual-task functional power training (DT-FPT)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 280
Study: 23665648

Group type: EXPERIMENTAL
Intervention: Microthin DSAEK technique
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional DSAEK technique
Number of subjects: 13
Study: 21864644

Group type: EXPERIMENTAL
Intervention: Mouthwash and toothpaste based on triclosan, fluoride, and mineral salts
Number of subjects: 30

Group type: COMPARATOR
Intervention: Salivary enzyme substitutes
Number of subjects: 30
Study: 19412117

Group type: EXPERIMENTAL
Intervention: d4T
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: ZDV
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: 3TC
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: abacavir
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: indinavir
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: efavirenz
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: nevirapine
Number of subjects: 416
Study: 18165536

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Non-treatment (non-IVIG)
Number of subjects: 31
Study: 15447699

Group type: EXPERIMENTAL
Intervention: Rizatriptan
Number of subjects: 728
Study: 11321381

Group type: EXPERIMENTAL
Intervention: LCP-enriched preterm formula
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard preterm formula
Number of subjects: 23

Group type: COMPARATOR
Intervention: Expressed breast milk
Number of subjects: 23
Study: 9725477

Group type: EXPERIMENTAL
Intervention: 200 mg ipriflavone tablets three times daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: 300 mg Scherer capsules twice daily
Number of subjects: 12
Study: 7975835

Group type: EXPERIMENTAL
Intervention: Booster vaccine (5 infants)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: One-dose vaccine (18 infants)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (18 infants)
Number of subjects: 41
Study: 2658898

Group type: EXPERIMENTAL
Intervention: Intravenous porcine intestinal mucosal heparin
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Subcutaneous porcine intestinal mucosal heparin
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Porcine intestinal mucosal heparin (both routes)
Number of subjects: 193
Study: 4976123

Group type: EXPERIMENTAL
Intervention: Trasicor (beta-adrenergic blocking drug)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31285738

Group type: EXPERIMENTAL
Intervention: Single strain probiotics, once daily for fourteen days
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mixed strain probiotics, once daily for fourteen days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 17
Study: 28341918

Group type: EXPERIMENTAL
Intervention: Dasatinib
Number of subjects: 49
Study: 25423653

Group type: EXPERIMENTAL
Intervention: Patients (Hoehn & Yahr stage 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 36
Study: 24601169

Group type: EXPERIMENTAL
Intervention: 7-day therapy with omeprazole (20 mg b.i.d.), levofloxacin (500 mg o.i.d.), and amoxicilline (1000 mg b.i.d.)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 10-day therapy with omeprazole (20 mg b.i.d.), levofloxacin (500 mg o.i.d.), and amoxicilline (1000 mg b.i.d.)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Both 7-day and 10-day therapies
Number of subjects: 105

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 105
Study: 20594551

Group type: COMPARATOR
Intervention: Recombinant FSH alone (group 1)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Recombinant FSH with Ganirelix when the leading follicle was ≥13 mm (group 2)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Recombinant FSH with Ganirelix from the beginning of stimulation (group 3)
Number of subjects: 98
Study: 18494346

Group type: EXPERIMENTAL
Intervention: Thick flap group (160-microm flap)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Thin flap group (110-microm flap)
Number of subjects: 28
Study: 15261932

Group type: EXPERIMENTAL
Intervention: 300 mg irbesartan (IRB)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20 mg enalapril (ENAL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 48
Study: 11600825

Group type: EXPERIMENTAL
Intervention: Nelfinavir 750 mg tid + ZDV 200 mg tid + 3TC 150 mg bid
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Nelfinavir 500 mg tid + ZDV 200 mg tid + 3TC 150 mg bid
Number of subjects: 297

Group type: COMPARATOR
Intervention: ZDV 200 mg tid + 3TC 150 mg bid + placebo
Number of subjects: 297
Study: 9636854

Group type: EXPERIMENTAL
Intervention: Sparfloxacin (200 mg once daily following a 400 mg loading dose on day 1)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Amoxicillin (1 g oral dose three times daily)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Sparfloxacin
Number of subjects: 329
Study: 8082507

Group type: EXPERIMENTAL
Intervention: ursodiol, 1200 mg/day
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ursodiol
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: open-label ursodiol
Number of subjects: 22
Study: 2721115

Group type: EXPERIMENTAL
Intervention: Cigarette smokers
Number of subjects: 83

Group type: COMPARATOR
Intervention: Healthy non-smokers
Number of subjects: 83
Study: 30944045

Group type: EXPERIMENTAL
Intervention: Oxytocin (40 IU)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 30503128

Group type: EXPERIMENTAL
Intervention: Post-warming culture for 1 hour (Group A)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Post-warming culture for 18 hours (Group B)
Number of subjects: 162
Study: 27666738

Group type: EXPERIMENTAL
Intervention: Stratified treatment strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 24368437

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D₃/d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D₃/d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: 4000 IU vitamin D₃/d
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328
Study: 22289903

Group type: EXPERIMENTAL
Intervention: Preoperative IABP starting at 12 hours (12T)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Preoperative IABP starting at 2 hours (2T)
Number of subjects: 230
Study: 21336428

Group type: COMPARATOR
Intervention: Diet I (low fat) in control group
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Diet I (low fat) in NAFLD group
Number of subjects: 162

Group type: COMPARATOR
Intervention: Diet II (low carbohydrate) in control group
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Diet II (low carbohydrate) in NAFLD group
Number of subjects: 162
Study: 19137905

Group type: EXPERIMENTAL
Intervention: Estomine‐zee (escitalopram oxalate 10 mg and clonazepam 0.5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Commercially available formulation (escitalopram oxalate 10 mg and clonazepam 0.5 mg)
Number of subjects: 24
Study: 15913460

Group type: EXPERIMENTAL
Intervention: Centralised information resource for clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Database containing standardised information for each trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Access via the Internet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Development of a centralised information resource
Number of subjects: 0
Study: 11277446

Group type: EXPERIMENTAL
Intervention: Monotic aftereffect (1-kHz adapting stimulus)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Interotic aftereffect (adapting 1 ear and testing the other ear)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Non-adaptation control condition
Number of subjects: 2
Study: 9517277

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin eardrops
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tobramycin eardrops
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo eardrops
Number of subjects: 60
Study: 8038980

Group type: EXPERIMENTAL
Intervention: Isoflurane followed by propofol infusion (ISO‐PRO group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isoflurane anesthesia only (ISO group)
Number of subjects: 60
Study: 3058135

Group type: EXPERIMENTAL
Intervention: Levodropropizine
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174

Group type: COMPARATOR
Intervention: Morclofone
Number of subjects: 174

Group type: COMPARATOR
Intervention: Cloperastine
Number of subjects: 174
Study: 30987852

Group type: EXPERIMENTAL
Intervention: RSV F subunit vaccine with aluminum hydroxide adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RSV F subunit vaccine with MF59 adjuvant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RSV F subunit vaccine without adjuvant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27788579

Group type: EXPERIMENTAL
Intervention: Pradigastat
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 25226273

Group type: EXPERIMENTAL
Intervention: Lipid emulsion containing 10% fish oil
Number of subjects: 159

Group type: COMPARATOR
Intervention: Fish oil-free lipid emulsion
Number of subjects: 159
Study: 23996211

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg
Number of subjects: 24
Study: 21050695

Group type: EXPERIMENTAL
Intervention: 20-hour communication skills course based on the Four Habits model
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 72
Study: 19850786

Group type: EXPERIMENTAL
Intervention: Pantoprazole granules with apple juice orally
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pantoprazole granules with apple juice via nasogastric tube
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pantoprazole granules with applesauce orally
Number of subjects: 25
Study: 18330097

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Radical surgery (RS)
Number of subjects: 5
Study: 14685005

Group type: EXPERIMENTAL
Intervention: Pimagedine 150 mg
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Pimagedine 300 mg
Number of subjects: 690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Pimagedine (both doses)
Number of subjects: 690
Study: 11298092

Group type: EXPERIMENTAL
Intervention: 15 mg MMI
Number of subjects: 71

Group type: COMPARATOR
Intervention: 150 mg PTU
Number of subjects: 71
Study: 9598512

Group type: EXPERIMENTAL
Intervention: Combined orchiectomy and radiotherapy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 91
Study: 7884369

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 347
Study: 29426811

Group type: EXPERIMENTAL
Intervention: Intralesional cryotherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Excision followed by brachytherapy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Excision with corticosteroid injections
Number of subjects: 26
Study: 26377167

Group type: EXPERIMENTAL
Intervention: Apical pacing
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Outflow tract pacing
Number of subjects: 21
Study: 24750284

Group type: EXPERIMENTAL
Intervention: Pasireotide 300 μg s.c. t.i.d.
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 22314891

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 197

Group type: COMPARATOR
Intervention: TVT-S H
Number of subjects: 197

Group type: COMPARATOR
Intervention: TVT-S U
Number of subjects: 197
Study: 20657263

Group type: EXPERIMENTAL
Intervention: Neck Disability Index
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Patient-Specific Functional Scale
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Numeric Pain Rating Scale
Number of subjects: 165
Study: 18172860

Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 1616

Group type: EXPERIMENTAL
Intervention: Sex hormone-binding globulin (SHBG)
Number of subjects: 1616

Group type: EXPERIMENTAL
Intervention: Androstenedione (Delta4-A)
Number of subjects: 1616

Group type: EXPERIMENTAL
Intervention: 3alpha-androstanediol glucuronide (3alpha-diolG)
Number of subjects: 1616
Study: 16980867

Group type: EXPERIMENTAL
Intervention: Laser-assisted lipoplasty
Number of subjects: 25

Group type: COMPARATOR
Intervention: Suction-assisted lipoplasty
Number of subjects: 25
Study: 14610472

Group type: EXPERIMENTAL
Intervention: SNP -654
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: SNP +46
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: SNP +523
Number of subjects: 707

Group type: EXPERIMENTAL
Intervention: Haplotypes of B2AR variants
Number of subjects: 707
Study: 11302008

Group type: EXPERIMENTAL
Intervention: Berry group (100 g of deep-frozen berries daily for 8 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Supplement group (100 mg of alpha-tocopherol and 500 mg of ascorbic acid daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (500 mg of calcium gluconate daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Berry group (80 g of each of the three berries in one go for short-term experiment)
Number of subjects: 60
Study: 8635703

Group type: EXPERIMENTAL
Intervention: Injection therapy (adrenaline and polidocanol)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Heater probe thermocoagulation (10F probe, at setting of 30 J)
Number of subjects: 104
Study: 1425135

Group type: EXPERIMENTAL
Intervention: Acyclovir with corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acyclovir alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acyclovir ointment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral Acyclovir
Number of subjects: 0
Study: 3883972

Group type: EXPERIMENTAL
Intervention: Levobunolol hydrochloride (0.5% and 1%)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Timolol maleate (0.5%)
Number of subjects: 141
Study: 30478992

Group type: COMPARATOR
Intervention: Fasting glucose levels categorized as <6.1 mmol/l (reference), 6.1-7.0 mmol/l (2nd), ≥7.0 mmol/l (3rd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-reported diabetes
Number of subjects: 0
Study: 30439313

Group type: EXPERIMENTAL
Intervention: Venturi combined with MR850 device active warm and humid oxygen therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ordinary flow device and warm and humid exchanger (artificial nose, HME) passive humid oxygen therapy
Number of subjects: 80
Study: 26252574

Group type: EXPERIMENTAL
Intervention: D-mix (3 g/dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 24925605

Group type: EXPERIMENTAL
Intervention: Chocolate frog incentive
Number of subjects: 137

Group type: COMPARATOR
Intervention: No chocolate frog incentive (Control)
Number of subjects: 137
Study: 23255845

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100